Latest News

Buying assets when they're expensive and then selling them when they're cheap tends to be a poor strategy.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up ...

The S&P 500 has soared 78% over the past three calendar years.

The XRP cryptocurrency is down sharply from last year's record high, but history suggests it could fall further.

Weekly credit card payments keep reported balances low, trim interest on carried debt, and make missed due dates far less likely. Here's how it works.

The two blockchain networks have been rivals for years.

Life sciences company Avantor (NYSE:AVTR) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 4.6% year on year to $1.70 billion. Its non-GAA...

Defense contracts provide early, reliable revenue for both companies and strengthen their investment case.

Power generation products company Generac (NYSE:GNRC) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 16.2% year on year to $1.29 bill...

Tesla's capital spending is soaring as it expands beyond electric vehicles.

Basf (ETR:BAS) reported higher third-quarter earnings before special items, supported by price increases, volume growth and lower fixed costs across its core businesses, while narrowing its full-year earnings outlook upward. EBITDA before special items rose 15% year over year to €1.6 billion in the

Aston Martin Lagonda Global (LON:AML) said its year-to-date performance through the third quarter of 2026 reflected progress toward its strategic and financial goals, with improved profitability, lower free cash outflow and a stronger liquidity position. Chief Financial Officer Doug Lafferty said c

ProKidney (NASDAQ:PROK) said it remains on track to report top-line results from the interim analysis of its Phase III PROACT 1 study in the second quarter of 2027, following stronger-than-expected patient recruitment for its investigational autologous cell therapy, rilparencel. Chief Executive Off

A few stocks will likely see big revenue boosts from SpaceX's spending.

American Express is down significantly in 2026, even as the major indexes are within striking distance of all-time highs.

Dividends, innovation, and valuation are just some of the reasons Berkshire’s bosses never want to let these stocks go.

The Bitcoin bull recently gave one of his more reasonable price predictions.

Gold and silver have long attracted investors seeking protection against economic uncertainty, but these two popular ETFs offer different opportunities for those looking to own precious metals.

The stock may soon begin trading, but with poor financials and questionable growth opportunities, there are multiple reasons for investors to stay away.

Lululemon and McDonald's are two recognizable consumer brands with very different financial profiles, but the cheaper stock isn't necessarily the better long-term investment.

Biogen crushed third-quarter expectations early Tuesday, helped by its suite of newer products and leading to a guidance hike.